Electronic Skin Market Size, Share & Trends Analysis Report By Product, By Component (Stretchable Circuits, Photovoltaics Systems), By Sensors (Tactile Sensors, Chemical Sensors), By Application, By Region, And Segment Forecasts, 2022 - 2029

Report Overview

The global electronic skin market size wasvalued at USD 4.76 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 22.55% from 2022 to 2029.  Widening usage of electronic skin owing to its advantages such as self-healing and flexibility is a major driving factor. As the artificial skin mimics human sensing capabilities, it has wide applications in health monitoring technologies. The sensitivity and flexibility of human skin are some of the major factors that uniquely distinguish it from other wearable devices. The increasing number of product launches and speedy FDA approvals are also boosting the market growth. For instance, in May 2018, MC10, Inc. received FDA approval for its BioStamp nPoint system. Moreover, technological advancements in the field of electronic skin are also driving the market.

Wearable electronic devices with skin like properties provide a platform for real-time and continuous monitoring of human physiological signals such as temperature, tissue pressure, electrolyte balance, disease-related biomarker, and body motion. The market is expected to see many innovations in self-healing electronic skin, lightning electronic skin, and sweating electronic skin.

Rising research and development in the field of artificial skin is also adding growth to the market. Researchers in Korea have developed multitasking skin that can act like human skin and can sense temperature, pressure, and sound simultaneously. Scientists are continuously performing research activities to imitate olfactory, palate senses, and tactile sensing. Furthermore, the use of electronic skin in artificial prosthetics, biomedical, and robotic devices is also creating new avenues for the market.

The advent of 3D printing and artificial intelligence has garnered the interest of in the field of health monitoring, drug delivery, and therapeutic uses. Increasing acceptance of electronic skin in a wide array of its application such as cardiovascular, diabetes, detecting abnormality, and pregnancy is further developing the e-skin technology. A lot of ongoing studies are focused on studying these technologies, especially in combination.

Product Insights

Electronic skin patches dominated the market and accounted for a revenue share of 91.5% in 2019. Electronic skin patches include actuators, sensors with appropriate processing, communication, and energy storage. The electronic skin patches are gaining traction owing to its use in various applications of personal care. This technology keeps patients out of the hospitals, while still maintain close contact with doctors. These electronic patches are used in diabetes self-monitoring, motion sensing, remote patient monitoring- both inpatient and outpatient, & temperature sensing.

The electronic suits segment is expected to grow at the fastest pace during the forecast period. Electronic textiles are products that involve both textile and electronic components. Humans are in contact with textiles all the time and it acts as an excellent interface to connect sensors with the body. Electronic suits are a highly convenient and effective solution for patient monitoring if its action is based on feedback temperature and pressure coming from the body. In addition, the electronic skin suits market is now shifting towards sports to healthcare.

Component Insights

Stretchable circuits dominated the market and accounted for a revenue share of 30.0% in 2019. Stretchable circuits provide a novel platform to interface with soft tissue for regenerative medicine, continuous health monitoring, and robotic control and feedback. In addition, these stretchable circuits allow various biosignals to be measured on human skin without restricting daily activities.

Electroactive Polymers (EAP) also account for the significant market share owing to biocompatible nature. EAP are polymers that undergo dimensional changes in response to the applied electrical field. These electroactive polymers are electronically conductive with high reversible ion storage capacity. These are a special class of material, with the ability to conform to the surface of different shapes and have low-moduli high strain capabilities. These features are getting traction for various applications of wearable sensors and interfacing with soft tissue.

Sensors Insights

Electrophysiological sensors dominated the market and accounted for a revenue share of around 40.0% in 2019. This is owing to the increasing use of these sensors in various applications of healthcare such as restoration therapies, chronic disease, and physiological monitoring. Moreover, the segment is witnessing a high adoption rate due to the increasing aging population. This sensor provides great assistance to the aging population which requires frequent medical interventions through telehealth, telemedicine, and home health monitoring.

The tactile sensors segment is expected to grow at an exponential growth rate during the forecast period. The key drivers of the segment are the high adoption rate of this technology in the field of robotic operation, human-machine interface, and physiological monitoring. Technological advancement and innovation in the field of wearable devices using tactile sensors are expected to boost segment growth. However, the research of flexible tactile sensors on wide sensing range, high sensitivity, and capability to detect 3D forces is still challenging the market.

Application Insights

The health monitoring segment dominated the market and accounted for a revenue share of 38.0% in 2019. This is owing to its high usage in various healthcare applications such as diabetes, cardiology, and neurology. Furthermore, the user-friendly nature of this technology allows the patient to apply patches for muscle, heart, and brain activity tests on their own.

The drug delivery systems segment is expected to witness the fastest CAGR during the forecast period. The high growth rate of the segment is primarily due to its non-invasive, real-time dynamic therapy function. These electronic skins can store data, use muscle movement, and use stored data patterns to deliver medicine through the skin. Thus, the above-mentioned factors are accepted to boost the demand for the market.

Regional Insights

North America dominated the market in 2019 and accounted for a revenue share of 39.0%. The region is expected to maintain its dominance over the forecast period. Regionally, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa(MEA). The rising number of geriatric population and the increasing number of product launches are boosting the market in North America. Continuous technological advancement and favorable reimbursement policies are also contributing to the growth of the market in the region. In addition, the presence of major players in the industry is further augmenting the growth in the region.

In the Asia Pacific, the market is likely to witness the fastest growth rate during the forecast period. The rising geriatric population and an increasing number of diabetes patients are the major factors contributing to market growth. According to the American Diabetes Association, more than 60.0% of the people with diabetes live in Asia. In addition, the steep rise in the aging population is also increasing the demand for the electronic skin market. According to the UNFPA, by 2050 one in four people in the Asia Pacific will be over 60 years old.

Key Companies & Market Share Insights

Key players are focusing on the miniaturization of products and continuous technological development. The major players in the industry are investing in research and development activities and are continuously innovating their products. For Instance, in October 2018, ViVaLNK and Reckitt Benkiser announced a partnership to distribute wearable continuous temperature monitor worldwide. The product Nurofen FeverSmart, and Enfasmart FeverSense are used by parents to track temperature changes in their child to take immediate action. These are CE certified and FDA cleared products are electronic skin patches that continuously monitor changes in body temperature.

The players in the industries are focusing on electronic skin patches in various applications such as artificial prosthetics, biomedical, instrumentation, industrial robotics, and humanoids. Due to its very peculiar features, these players are focusing on electronic skin using a holistic approach. Moreover, companies are focusing on the implementation of artificial intelligence and machine learning in electronic skin development. Some of the prominent players in the electronic skin market include:

• MC10

• Xenoma

• VivaLNK

• GENTAG, Inc

• DIALOG Semiconductors

• Bloomlife

Recent Developments

• In August 2022, Xenoma and CYBERDYNE, two companies in the cutting-edge fields of printed circuit fabric and Cybernics, joined forces to create solutions that help users to carry out their physical functions in their daily lives.

Electronic Skin Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2029. For the purpose of this study, Grand View Research has segmented the global electronic skin market report based on the product, component, sensors, application, and region:

• Product Outlook (Revenue, USD Million, 2017 - 2029)

  • Electronic skinsuits

  • Electronic patches

• Component Outlook (Revenue, USD Million, 2017 - 2029)

  • Stretchable circuits

  • Photovoltaics systems

  • Stretchable conductors

  • Electroactive polymers

• Sensors Outlook (Revenue, USD Million, 2017 - 2029)

  • Tactile sensors

  • Chemical sectors

  • Electrophysiological Sensors

  • Others

• Application Outlook (Revenue, USD Million, 2017 - 2029)

  • Health monitoring systems

  • Drug delivery systems

  • Cosmetics

• Regional Outlook (Revenue, USD Million, 2017 - 2029)

  • North America

    • The U.S.

    • Canada

  • Europe

    • The U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE